MANUEL
PRAGA TERENTE
Profesor emérito
University of Glasgow
Glasgow, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Glasgow (4)
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
2021
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
2017
-
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
The Lancet, Vol. 389, Núm. 10084, pp. 2117-2127
2013
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503